On Thursday, Zimmer Holdings Inc. (NYSE:ZMH) said it will pay $10.35 billion in cash and issue shares of its common stock valued at $3 billion to Biomet Inc.’s equity holders. The firms said the deal’s total value also includes the assumption of an unspecified amount of debt. Zimmer Holdings, Inc. (NYSE:ZMH) shares after opening at $107.00 moved to $108.33 on last trade day and at the end of the day closed at $101.97. Company price to sales ratio in past twelve months was calculated as 3.72 and price to cash ratio as 9.51. Zimmer Holdings, Inc. (NYSE:ZMH) showed a positive weekly performance of 11.36%.
Allergan, Inc.’s (NYSE:AGN) management unanimously adopted a poison pill strategy Tuesday after it became aware that its common stock had been rapidly accumulated over the last two months by activist investor Bill Ackman and rival firm Valeant Pharmaceuticals Intl Inc. (VRX). Allergan, Inc. (NYSE:AGN) shares advanced 0.58% in last trading session and ended the day on $166.61. AGN return on equity ratio is recorded as 14.70% and its return on assets is 8.80%. Allergan, Inc. (NYSE:AGN) yearly performance is 50.25%.
On April 18, 2014, Kenneth B. Lee, Jr., a member of the Board of Directors of POZEN Inc. (NASDAQ:POZN) and Chairman of the Compensation Committee of the Board, sent a letter to certain POZEN stockholders to apprise them of certain undertakings of the Compensation Committee of the Board relating to POZEN’s annual meeting of stockholders, scheduled for June 4, 2014. POZEN Inc. (NASDAQ:POZN) shares moved up 4.12% in last trading session and was closed at $9.60, while trading in range of $9.02 – $9.69. POZEN Inc. (NASDAQ:POZN) year to date (YTD) performance is 19.40%.
Michael W. Beal is the new president of the Kindred Healthcare, Inc. (NYSE:KND) Nursing Centre Division. He will be on the executive committee. Kindred Healthcare, Inc. (NYSE:KND) weekly performance is 7.26%. On last trading day company shares ended up $26.01. Kindred Healthcare, Inc. (NYSE:KND) distance from 50-day simple moving average (SMA50) is 15.97%. Analysts mean target price for the company is $24.25.